G Zoppetti

Heparin by alternative routes of administration.

G Andriuoli, M Bossi, I Caramazza, 1990, Haemostasis.

Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.

M. Rusnati, M. Presta, M Rusnati, 1994, The Biochemical journal.

Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.

D. Ribatti, M. Rusnati, M. Presta, 2001, The Journal of biological chemistry.